Articles by Daniel Marsh
NuScale Shares Slide 5.5% as AI Gains Fail to Offset Revenue Gap
NuScale Power shares dropped 5.5% on Wednesday, erasing AI-driven gains, as investors weighed efficiency improvements against a 99% revenue decline and rising R&D costs.
Netflix's 'Emily in Paris' Finale Set for December 24; Stock Slips 0.9%
Netflix will premiere the sixth and final season of 'Emily in Paris' on December 24. Shares dropped 0.9% to $81.46, wiping out $3.2 billion in market value.
Oracle Gains 2.8% as Citi Flags Upcoming Catalysts, Market Cap Jumps $12B
Oracle shares climbed 2.8% after Citi started a 90-day catalyst watch, boosting market value by $12B. Analysts remain bullish despite negative free cash flow.
Volato Stock Skyrockets 62% on $500M AI Infrastructure Merger Deal
Volato (SOAR) shares jumped 62% after announcing a $500M merger with AI infrastructure firm Alignment Engine, a deal 38 times its market cap.
Expion Energy Stock Soars 60% as Fundraising Nearly Matches Market Cap
Expion Energy (XPON) shares jumped 60% after raising $8.2 million, nearly matching its market cap. The battery firm is pivoting to Louisiana gas exploration.
Mitsubishi Motors Rally on Pajero Comeback Plans
Mitsubishi Motors shares gained 2.5% as investors anticipate the September 2 global debut of the 2027 Pajero, a key model for the company's sales and profit targets.
Biohaven Stock Soars 25% on Trade Secret Ruling
Biohaven shares surged 25% after a federal court finalized a $4 million trade secret ruling, boosting market cap by $553 million as investors bet on platform value.
MG Hector Tomahawk EV and PHEV Launch in India; SAIC Expands Market Presence
MG Hector Tomahawk EV starts at ₹1.95 million, with battery rental reducing entry price. PHEV variant offers 1,100 km range. SAIC shares rise 0.78%.
Loblaw Revives Tariff Tags, Highlights Margin Sensitivity
Loblaw brings back 'T' tariff labels on shelves as trade friction widens, with CEO Per Bank noting stronger supply chain diversification.
Asia Chip Stocks Pare Losses as KASE Global Wraps Up; PCE Inflation Pressures Fed Bets
Asian chip stocks narrowed losses as KASE Global entered its final hour, while a hotter-than-expected US PCE inflation report lifted Fed hike odds and pressured rate-sensitive growth stocks.
FDA Approves Rasonque, Revolution Medicines Stock Holds Steady
Revolution Medicines (RVMD) received FDA approval for Rasonque in pancreatic cancer, but shares rose only 0.8% as investors awaited launch details.